Cingulate Stock (NASDAQ: CING) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 1.018K / 1.738M |
Day Range | - - - |
52 Wk Range | 1.000 - 23.798 |
Market Cap | $5.275M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 2.48% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cingulate (NASDAQ: CING) through any online brokerage.
Other companies in Cingulate’s space includes: 60 Degrees (NASDAQ:SXTP), Kiora Pharmaceuticals (NASDAQ:KPRX), Universe Pharmaceuticals (NASDAQ:UPC), Jaguar Health (NASDAQ:JAGX) and Palisade Bio (NASDAQ:PALI).
The latest price target for Cingulate (NASDAQ: CING) was reported by HC Wainwright & Co. on Friday, January 5, 2024. The analyst firm set a price target for 8.00 expecting CING to rise to within 12 months (a possible 633.94% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Cingulate (NASDAQ: CING) is $1.09 last updated Today at March 28, 2024 at 9:15 AM EDT.
There are no upcoming dividends for Cingulate.
Cingulate’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for Cingulate.
Cingulate is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.